NCT02321917View on ClinicalTrials.gov

Rheoparin-coated Tubing System for Minimized Extracorporeal Circulation (MECC)

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

November 30, 2019

Study Completion Date

December 31, 2019

Conditions
Extracorporeal CirculationInflammationBlood CoagulationIntracranial Embolism
Interventions
DEVICE

MECC system with rheoparin coating

MECC system for extracorporeal circulation equipped with rheoparin coating.

Trial Locations (2)

3010

Dep. Cardiovascular Surgery, Bern

Inselspital, University Hospital Bern, University of Bern, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT02321917 - Rheoparin-coated Tubing System for Minimized Extracorporeal Circulation (MECC) | Biotech Hunter | Biotech Hunter